Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / YuanBio Venture Capital
Entity

YuanBio Venture Capital

Tracked across 1 events · 6 articles · First seen Jul 20, 2026 · Last active Aug 12, 2026

Sentiment
50
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 50
Business
Beyang Therapeutics closes $30M Series A
Bicara Therapeutics, an AI-driven drug discovery company based in Chengdu, China, announced the successful closing of an oversubscribed Series A financing round, raising nearly $30 million. The round was co-led by Legend Holdings and Shanghai…
Impact: YuanBio Venture Capital continued its support, demonstrating ongoing confidence in Beyang's platform and pipeline. This investment may yield significant returns if the company succeeds.
Jul 20, 2026 · 6 articles
Key Actions (1)
60 YuanBio Venture Capital continued support Bicara TherapeuticsBeyang Therapeutics closes...
ERGEN INTELLIGENCE
Track YuanBio Venture Capital live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.